The purpose of this funding opportunity is to support research to advance the development of safe and effective medications for the treatment of Substance Use Disorders (SUD). It includes preclinical and/or clinical research projects, from lead optimization all the way Phase I, Phase II, and Phase III clinical trials. The goal is to fund studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval.
This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP).
Deadlines:
- Letter of Intent Due Dates: 30 days before the application due date
- Application Due Date(s): April 10, 2025; August 11, 2025
PAR-25-328 Expiration Date August 12, 2025
Application budgets are limited to $5 million per year for direct costs and need to reflect the actual needs of the proposed project.
The maximum period of support is 3 years.